Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4720-4727

  Singha, Harisankar ^a   Mallick, Amirul Islam ^b,c   Jana, Chandrakanta ^a   Fatima, Nishat ^b   Owais, Mohammad ^b   Chaudhuri, Pallab ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brucella abortus; Cu Zn superoxide dismuatse (SOD); Escheriosomes; Interleukin 18 (IL 18)

Indexed keywords

BACTERIAL VACCINE; LIPOSOME; RECOMBINANT COPPER ZINC SUPEROXIDE DISMUTASE PROTEIN; RECOMBINANT INTERLEUKIN 18; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRUCELLA ABORTUS; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 79960632676     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.088     Document Type: Article

References (52)

1. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997;3(2):213-21.
2. DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci USA 2002;99(1):443-8.
3. Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci USA 2002;99(20):13148-53.
4. Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, Gorvel JP. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 2003;198(4):545-56.
5. Halling SM, Peterson-Burch BD, Bricker BJ, Zuerner RL, Qing Z, Li LL, et al. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J Bacteriol 2005;187(8):2715-26.
6. Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 1991;28(2):171-88.
7. Deyoe BL, Dorsey TA, Meredith KB, Garrett L. Effect of reduced dosages of Brucella abortus strain 19 in cattle vaccinated as yearlings. Proc Annu Meeting US Anim Health Assoc 1979;83:92-104.
8. Nicoletti P, Vaccination. In: Nielsen K, Duncan JR, editors. Animal brucellosis. Boca Raton: CRC Press; 1990. p. 284-99.
9. Smith R, Kapatsa JC, Sherwood 3rd SJ, Ficht TA, Templeton JW, et al. Differential reactivity of bovine lymphocytes to species of Brucella. Am J Vet Res 1990;51(4):518-23.
10. Oliveira SC, Splitter GA. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996;14(10):959-62.
11. Kurar E, Splitter GA. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 1997;15(17-18):1851-7.
12. Onate AA, Vemulapalli R, Andrews E, Schurig GG, Boyle S, Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun 1999;67(2):986-8.
13. Vemulapalli R, He Y, Cravero S, Sriranganathan N, Boyle SM, Schurig GG. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 2000;68(6):3286-9.
14. Onate AA, Cespedes S, Cabrera A, Rivers R, Gonzalez A, Munoz C, et al. A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 2003;71(9):4857-61.
15. Onate AA, Donoso G, Moraga-Cid G, Folch H, Cespedes S, Andrews E. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu-Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 2005;73(6):3294-300.
16. Gonzalez-Smith A, Vemulapalli R, Andrews E, Onate A. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2. Immunobiology 2006;211(1-2):65-74.
17. Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, et al. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 2009;77(1):436-45.
18. Yang Y, Yin J, Guo D, Lang X, Wang X. Immunization of mice with recombinant Sadenosyl-l homocysteine hydrolase protein confers protection against Brucella melitensis infection. FEMS Immunol Med Microbiol 2011;61:159-67.
19. Beck BL, Tabatabai LB, Mayfield JE. A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase. Biochemistry 1990;29:372-6.
20. Bricker BJ, Tabatabai LB, Judge BA, Deyoe BL, Mayfield JE. Cloning, expression and occurrence of the Brucella Cu-Zn superoxide dismutase. Infect Immun 1990;58:2935-9.
21. Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 2008;364(2):272-80.
22. Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, et al. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am J Vet Res 1996;57(5):677-83.
23. Denisov AA, Korobovtseva YS, Karpova OM, Tretyakova AV, Mikhina LV, Ivanov AV, et al. Immunopotentiation of live brucellosis vaccine by adjuvants. Vaccine 2010;28(15):17-22.
24. Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, et al. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Vaccine 2007;25(18):3692-704.
25. Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, et al. Escheriosomemediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis. Vaccine 2007;25(46):7873-84.
26. Singha H, Mallick AI, Jana C, Isore DP, Goswami TK, Srivastava SK, et al. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus. Microbes Infect 2008;10(10-11):1089-96.
27. Ahmad N, Khan MA, Owais M. Liposome mediated antigen delivery leads to induction of CD8+ T lymphocyte and antibody responses against the V3 loop region of HIV gp120. Cell Immunol 2001;210(1):49-55.
28. Dupre L, Kremer L, Wolowczuk I, Riveau G, Capron A, Locht C. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 2001;19(11-12):1373-80.
29. Thalhamer J, Leitner W, Hammerl P, Brtko J. Designing immune responses with genetic immunization and immunostimulatory DNA sequences. Endocr Regul 2001;35(3):143-66.
30. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80(3): 147-62.
31. Rosinha GM, Myioshi A, Azevedo V, Splitter GA, Oliveira SC. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation. J Med Microbiol 2002;51(8):661-71.
32. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73(2):213-24.
33. Zhu M, Xu X, Liu H, Liu X, Wang S, Dong F, et al. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant. J Med Microbiol 2003;52(Pt 3):223-8.
34. Kikuchi H, Kim S, Watanabe K, Watarai M. Brucella abortus d-alanyl-d-alanine carboxypeptidase contributes to its intracellular replication and resistance against nitric oxide. FEMS Microbiol Lett 2006;259(1):120-5.
35. Shi XJ, Wang B, Wang M. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine 2007;25(7):1257-64.
36. Ramos-Payan R, Aguilar-Medina M, Estrada-Parra S, Gonzalez-Y-Merchand JA, Favila-Castillo L, Monroy-Ostria A, et al. Quantification of cytokine gene expression using an economical real-time polymerase chain reaction method based on SYBR Green I. Scand J Immunol 2003;57(5):439-45.
37. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, et al. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun 2001;69(10):6264-70.
38. Cespedes S, Andrews E, Folch H, Onate A. Identification and partial characterisation of a new protective antigen of Brucella abortus. J Med Microbiol 2000;49(2):165-70.
39. Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, Bowden RA, et al. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 2002;70(5):2507-11.
40. Cassataro J, Velikovsky CA, de la Barrera S, Estein SM, Bruno L, Bowden R, et al. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun 2005;73(10):6537-46.
41. Kaushik P, Singh DK, Kumar SV, Tiwari AK, Shukla G, Dayal S, et al. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides. Vet Res Commun 2010;34(2):119-32.
42. Bhattacharjee AK, Izadjoo MJ, Zollinger WD, Nikolich MP, Hoover DL. Comparison of protective efficacy of subcutaneous vs. intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect Immun 2006;74(10):5820-5.
43. Commander NJ, Brewer JM, Wren BW, Spencer SA, Macmillan AP, Stack JA. Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immuno genicity but fails to provide full protection against B. melitensis challenge. Genet Vaccines Ther 2010;8:5.
44. Tabatabai LB, Pugh Jr GW, Stevens MG, Phillips M, McDonald TJ. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice. Am J Vet Res 1992;53(10):1900-7.
45. Weynants V, Walravens K, Didembourg C, Flanagan P, Godfroid J, Letesson JJ. Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle. Vet Immunol Immunopathol 1998;66(3-4):309-20.
46. Murphy EA, Parent M, Sathiyaseelan J, Jiang X, Baldwin CL. Immune control of Brucella abortus 2308 infections in BALB/c mice. FEMS Immunol Med Microbiol 2001;32(1):85-8.
47. Munoz-Montesino C, Andrews E, Rivers R, Gonzalez-Smith A, Moraga-Cid G, Folch H, et al. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Infect Immun 2004;72(4):2081-7.
48. Leite-De-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, Schneider E, et al. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 1999;163(11): 5871-6.
49. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent co inducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999;162(9):5070-7.
50. Campbell E, Kunkel SL, Strieter RM, Lukacs NW. Differential roles of IL-18 in allergic airway disease: induction of eotaxin by resident cell populations exacerbates eosinophil accumulation. J Immunol 2000;164(2):1096-102.
51. Wild JS, Sigounas A, Sur N, Siddiqui MS, Alam R, Kurimoto M, et al. IFNgamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000;164(5):2701-10.
52. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, et al. IL-18 induction of IgE: dependence on CD4+ T cells IL-4 and STAT6. Nat Immunol 2000;1(2):132-7.